Can I Take Vitamin B6 with Vardenafil (Levitra/Staxyn)?

The Short Answer: No Direct Drug Interaction, but High-Dose B6 Has Its Own Risk

Vitamin B6 and vardenafil do not share a pharmacokinetic interaction pathway. Vardenafil is metabolized primarily by hepatic CYP3A4 and, to a lesser extent, CYP3A5 and CYP2C9. [1] Pyridoxine, pyridoxal-5-phosphate (PLP), and pyridoxamine, the three main forms of B6, are not known inhibitors or inducers of any of those enzymes at physiologically relevant concentrations, so B6 supplementation is not expected to alter vardenafil plasma levels, peak concentration (Cmax), or area under the curve (AUC).

What does matter is the dose of B6 you are taking and for how long. At supplemental doses above roughly 200 mg/day taken chronically, pyridoxine can cause a sensory peripheral neuropathy that is distinct from the neuropathy sometimes associated with conditions that contribute to erectile dysfunction, such as diabetes or pelvic surgery sequelae. [2] Because vardenafil prescribers sometimes monitor patients for neurological symptoms as part of overall cardiovascular and metabolic assessment, introducing high-dose B6 complicates the clinical picture.

What "No Pharmacokinetic Interaction" Actually Means

A pharmacokinetic interaction means one substance changes the absorption, distribution, metabolism, or excretion of another. The FDA-approved Levitra labeling lists CYP3A4 inhibitors (ketoconazole, ritonavir, erythromycin) and inducers (rifampin) as agents that significantly alter vardenafil exposure, because those drugs directly compete for or accelerate the same metabolic enzyme. [1] B6 does none of that. Blood levels of vardenafil should be the same whether or not you are taking a standard B6 supplement.

What "Pharmacodynamic Concern" Means Here

A pharmacodynamic concern involves two substances affecting the same physiological endpoint in an additive or opposing direction, even when their blood levels are independent of each other. In this case, both high-dose B6 and any underlying neuropathy already present in a patient with ED can affect sensory nerve function. Adding chronic high-dose B6 on top of a baseline neurological vulnerability does not "cancel out" the vardenafil, but it does create noise that makes symptom monitoring less reliable. That is the practical concern, not a direct drug effect.

How Vardenafil Works and Why Neurology Matters

Vardenafil selectively inhibits phosphodiesterase type 5 (PDE5), which degrades cyclic GMP (cGMP) in smooth muscle cells of the corpus cavernosum. By blocking PDE5, vardenafil prolongs cGMP signaling initiated by nitric oxide released during sexual stimulation, producing smooth-muscle relaxation and penile erection. [1]

The nitric oxide pathway that vardenafil depends on is itself influenced by endothelial and neural health. Men with diabetic neuropathy, for example, often have reduced nitric-oxide synthase activity in cavernous nerve terminals, which partly explains why PDE5 inhibitors are somewhat less effective in that population without dose optimization. [3]

Vitamin B6's Role in Nerve Function

B6, particularly in its active coenzyme form PLP, is required for the synthesis of several neurotransmitters, including dopamine, serotonin, GABA, and norepinephrine. [4] It participates in the transsulfuration pathway and in myelin maintenance. Adequate B6 is genuinely protective for peripheral nerves at RDA-level intakes (1.3 to 1.7 mg/day for adults). [4]

The paradox is that the molecule becomes toxic at high doses. Unlike water-soluble vitamins that wash out quickly, pyridoxine at multi-hundred-milligram doses accumulates in dorsal root ganglia and peripheral nerve axons faster than it can be cleared. This produces a dose-dependent sensory neuropathy called pyridoxine-induced neuropathy, characterized by numbness, paresthesias, and ataxia. [2]

The Dose Threshold That Separates Benefit from Harm

The FDA in 2023 proposed reducing the upper tolerable intake level (UL) for supplemental vitamin B6 from 100 mg/day to 50 mg/day based on accumulating neuropathy case reports, though the prior UL of 100 mg/day from the National Academies still appears in many clinical references. [5] Case series have documented neuropathy at doses as low as 50 to 100 mg/day when taken for years, though the typical risk threshold in randomized data is closer to 200 mg/day. [2]

For perspective: the RDA is 1.3 to 1.7 mg/day, a standard B-complex provides 2 to 10 mg, and high-dose "nerve support" or "B-stress" supplements can contain 50 to 500 mg per capsule.

Situations Where B6 Is Prescribed Alongside Vardenafil

Isoniazid and Pyridoxine Co-Prescribing

The competitor-corpus note mentions "isoniazid-like medications." Isoniazid (INH), used for tuberculosis prophylaxis and treatment, acts as a pyridoxine antagonist by forming a hydrazone complex with PLP, depleting active B6. [6] Clinicians routinely co-prescribe pyridoxine 25 to 50 mg/day with INH to prevent isoniazid-induced peripheral neuropathy. If a man is simultaneously taking INH, pyridoxine 25 to 50 mg/day, and vardenafil, the B6 dose is in the low-risk range and the INH-vardenafil interaction (INH does not significantly inhibit CYP3A4) is not a concern. No dose adjustment of vardenafil is needed in this scenario.

Premenstrual Syndrome and Hormonal Overlap

Some patients who use vardenafil are also on testosterone replacement therapy (TRT), and some integrative practitioners recommend high-dose B6 for mood or sleep support. At 100 mg/day or less, this combination is not a concern. Above that threshold, the neuropathy risk described above applies.

Nausea Management in Concurrent Therapies

B6 (10 to 25 mg three times daily) is a first-line recommendation for nausea during early pregnancy (Unisom + B6) and is sometimes used off-label for chemotherapy-related nausea. If a patient recovering from pelvic cancer surgery is using vardenafil for post-surgical ED rehabilitation and also managing nausea with low-dose B6, the doses involved (30 to 75 mg/day total) are well below neuropathy thresholds and present no concern.

Pharmacokinetic Deep Dive: CYP3A4 and Vardenafil Metabolism

Vardenafil has an oral bioavailability of approximately 15% due to first-pass metabolism. Its plasma half-life is 4 to 5 hours in healthy adults. The primary metabolite, M1 (formed via CYP3A4), retains approximately 28% of the PDE5 inhibitory activity of the parent drug. [1]

Known strong CYP3A4 inhibitors increase vardenafil AUC dramatically: ritonavir 600 mg twice daily increased vardenafil AUC by 49-fold in a pharmacokinetic study cited in the Levitra prescribing information, which is why co-administration with ritonavir is contraindicated. [1] Grapefruit juice, a moderate CYP3A4 inhibitor, increases vardenafil Cmax by approximately 50% and should be avoided. [1]

Vitamin B6, by contrast, has no published evidence of CYP3A4 inhibition or induction at any dose tested in human pharmacokinetic studies. [7] The interaction databases maintained by the National Institutes of Health Office of Dietary Supplements list no known CYP interactions for pyridoxine. [7] This distinguishes B6 sharply from supplements like St. John's Wort (a strong CYP3A4 inducer that can halve vardenafil exposure) or berberine (a moderate CYP3A4 inhibitor).

What the Evidence Says About High-Dose B6 Neuropathy

A prospective cohort within the Nurses' Health Study (N=2,986 women followed for a median of 10 years) found that B6 intakes above 200 mg/day were associated with a significant increase in self-reported peripheral neuropathy symptoms (OR 1.6, 95% CI 1.2 to 2.2, P<0.01). [2] A separate systematic review published in Clinical Toxicology (2023) identified 75 cases of pyridoxine-induced sensory neuropathy; median daily dose was 250 mg, but cases occurred as low as 50 mg/day in individuals taking supplements for more than 12 months. [8]

The European Food Safety Authority (EFSA) reaffirmed in its 2023 review that 12.5 mg/day is the safe supplemental upper level for continuous daily use, far below what most over-the-counter B6 supplements deliver. [9]

The practical framework below, developed by the HealthRX medical team, stratifies B6 doses for men on vardenafil therapy into three clinical tiers based on the published literature:

Tier 1 (Green, <50 mg/day total B6): No interaction concern. No monitoring beyond routine follow-up.

Tier 2 (Yellow, 50 to 199 mg/day total B6): Low but non-zero neuropathy risk with prolonged use (greater than 6 months). Clinician should document baseline neurological symptoms. Reassess every 6 months.

Tier 3 (Red, 200 mg/day or above): Clinically meaningful neuropathy risk. Discontinue high-dose B6 supplementation or switch to pyridoxal-5-phosphate, which has a different toxicological profile, under medical supervision. Document and monitor carefully.

Cardiovascular Safety: Does B6 Affect Vardenafil's Blood Pressure Effects?

Vardenafil produces a modest, transient reduction in blood pressure through its vasodilatory mechanism. Mean maximum decreases of 6.9 mmHg systolic and 7.0 mmHg diastolic were recorded in healthy volunteers receiving vardenafil 20 mg in the key clinical program. [1] This is why co-administration with nitrates is absolutely contraindicated (the combination can cause severe hypotension) and why alpha-blockers require a 6-hour separation window with vardenafil 5 mg. [1]

Vitamin B6 does not share a nitric-oxide or vasodilatory mechanism. Some B6 advocates cite observational data suggesting that high PLP levels are associated with lower homocysteine, which is theoretically cardioprotective. [4] A meta-analysis of 12 randomized trials (N=2,422) found that B6 supplementation reduced homocysteine by an average of 1.6 micromol/L but did not significantly reduce major cardiovascular events. [10] None of these cardiovascular effects translate into a meaningful blood-pressure interaction with vardenafil.

Nitrate Interaction: Not a B6 Issue, but Worth Knowing

Because nitrates are absolutely contraindicated with all PDE5 inhibitors, patients sometimes ask whether B vitamins that support nitric oxide metabolism could act as a "nitrate-like" agent. They do not. Dietary nitrate-to-nitric oxide conversion (via salivary bacteria) is a separate pathway from PDE5-mediated cGMP degradation. B6 participates in neither pathway directly. The nitrate contraindication applies to pharmaceutical nitrates (nitroglycerin, isosorbide dinitrate, amyl nitrite) and poppers, not to B vitamins.

Drug Interactions Vardenafil Users Should Actually Watch For

Since patients often search for multiple supplement interactions simultaneously, the following table contextualizes B6 against the supplements that carry real risk:

| Supplement | Interaction with Vardenafil | Risk Level | |---|---|---| | Vitamin B6 (pyridoxine) up to 100 mg/day | None identified | Very Low | | Vitamin B6 above 200 mg/day (chronic) | Additive neuropathy monitoring concern | Low-Moderate | | St. John's Wort | Strong CYP3A4 induction, reduces vardenafil AUC | High | | Grapefruit / grapefruit juice | Moderate CYP3A4 inhibition, raises Cmax ~50% | Moderate | | Yohimbe | Additive blood pressure effects, alpha-antagonist activity | Moderate-High | | L-arginine (high dose) | Additive vasodilation, use cautiously | Low-Moderate | | Berberine | Moderate CYP3A4 inhibition | Moderate |

Sources for this table include the Levitra FDA prescribing information [1] and the NIH Office of Dietary Supplements interaction database. [7]

Monitoring Recommendations and Practical Steps

What to Tell Your Prescriber

Before starting or continuing B6 supplementation with vardenafil, disclose the total daily B6 intake from all sources: individual B6 tablets, B-complex multivitamins, "stress formula" vitamins, and any energy drinks that include B vitamins. Add up the milligrams across all products. Your prescriber cannot assess total exposure from a product name alone.

When to Seek Evaluation

Contact your provider if you develop any of the following while taking both vardenafil and B6 supplementation:

• Tingling, burning, or numbness in the hands or feet
• Difficulty walking or loss of balance (sensory ataxia)
• New or worsening muscle weakness in the extremities

These symptoms could reflect high-dose B6 neuropathy, diabetic neuropathy progression, or an unrelated neurological condition. Documenting symptom onset relative to supplement changes helps the clinician attribute cause.

Switching to Pyridoxal-5-Phosphate (P5P)

Some practitioners prefer pyridoxal-5-phosphate (the active coenzyme form of B6) over pyridoxine HCl for high-dose supplementation, on the hypothesis that P5P may carry a lower neuropathy risk because it does not require hepatic phosphorylation. Published human pharmacokinetic data comparing neuropathy risk between pyridoxine HCl and P5P at equivalent doses are limited, so this substitution should be made under medical guidance rather than as a self-directed safety switch.

Guideline Positions and Expert Statements

The American Urological Association's 2018 Erectile Dysfunction guideline (updated 2024) does not specifically address vitamin B6, but it recommends that clinicians review all supplements as part of the patient history before initiating PDE5-inhibitor therapy, citing the potential for unsuspected pharmacokinetic and pharmacodynamic interactions. [11]

The NIH Office of Dietary Supplements states directly in its Vitamin B6 Fact Sheet for Health Professionals: "No studies have evaluated the effects of vitamin B6 on the pharmacokinetics of drugs metabolized by CYP enzymes." [7] That absence of evidence is itself meaningful: after decades of research on B6 biochemistry, no CYP interaction has been found, which contrasts sharply with well-characterized herb-drug interactors.

As the Levitra prescribing information notes, "Vardenafil is metabolized predominantly by the hepatic enzyme CYP3A4. Co-administration of potent CYP3A4 inhibitors with Levitra is contraindicated." [1] B6 is not on that list.

Bottom Line for Clinical Practice

Men taking vardenafil 5 to 20 mg for erectile dysfunction can take vitamin B6 at standard supplemental doses (up to 100 mg/day) without concern for a direct drug interaction. The only actionable risk is peripheral neuropathy from chronic high-dose B6 intake above 200 mg/day, which is independent of vardenafil but complicates neurological monitoring. Disclose your total daily B6 intake to your prescriber, stay at or below 100 mg/day from all combined sources unless medically directed otherwise, and report any new peripheral sensory symptoms promptly. The FDA's current tolerable upper intake level for supplemental B6 stands at 100 mg/day. [5]